{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:00:19Z","timestamp":1791388819938,"version":"4.3.3"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    IgA nephropathy (IgAN) and membranous nephropathy (MN) are common glomerulonephritis, the presence of which in the same patient\u2013 concurrent of IgAN and MN (cIgAN\/MN) has been described occasionally. This study aims to show clinical-pathological features of cIgAN\/MN and attempts to suggest underlying pathogenesis using disease-specific biomarkers and a genomics approach. This retrospective cohort study described the clinical and pathological data from 137 patients with cIgAN\/MN diagnosed in Peking University First Hospital from 2005 to 2019. One hundred primary IgAN and 100 MN cases were randomly selected as disease controls between the same time interval. Moreover, disease-specific biomarkers and polygenic risk score models were conducted to reveal the underlying pathogenesis. The median age of the cIgAN\/MN cases was 45-year-old, and 46% were women. Compared to IgAN, patients with cIgAN\/MN had a higher level of 24-hour proteinuria excretion but lower microscopic hematuria. They had a lower median level of galactose-deficient IgA1 (Gd-IgA1, 4.00 versus 5.45 \u03bcg\/ml,\n                    <jats:italic>P<\/jats:italic>\n                    =0.002) as well as the standardized genetic risk scores of developing IgAN (GRSs: 0.05 versus 0.68,\n                    <jats:italic>P<\/jats:italic>\n                    &amp;lt;0.001). Compared to MN, patients with cIgAN\/MN had a lower proportion of nephrotic syndrome and a lower level of albumin-to-creatinine ratio. However, the 24-hour proteinuria levels, serum lipid profiles, proportion of hypertension, and pathology classification were similar. Patients with cIgAN\/MN had lower levels of plasma autoantibodies against the M-type transmembrane phospholipase A2 receptor (PLA2R) (11.23 versus 36.59 U\/ml,\n                    <jats:italic>P<\/jats:italic>\n                    =0.005). Intriguingly, there were no statistical differences in standardized GRSs of developing MN between them (2.77 versus 3.02,\n                    <jats:italic>P<\/jats:italic>\n                    =0.326). Compared to IgAN, cIgAN\/MN may lean towards MN more according to clinical-pathological features, disease-specific biomarker levels, and disease-specific genetic risk scores.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.846323","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T23:43:37Z","timestamp":1646955817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?"],"prefix":"10.3389","volume":"13","author":[{"given":"Jia-Wei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Feng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Fang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Cheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy022","article-title":"Primary Glomerular Nephropathy Among Hospitalized Patients in a National Database in China","volume":"33","author":"Li","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.10.018","article-title":"Management and Treatment of Glomerular Diseases (Part 1): Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"Floege","year":"2019","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11180821","article-title":"Time to Abandon Kidney Biopsy to Diagnose Membranous Nephropathy","volume":"16","author":"Ronco","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000183040","article-title":"An Overlapping Syndrome of IgA Nephropathy and Membranous Nephropathy","volume":"35","author":"Doi","year":"1983","journal-title":"Nephron"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1985.tb01021.x","article-title":"Coexistence of IgA Nephropathy and Membranous Nephropathy","volume":"35","author":"Kobayashi","year":"1985","journal-title":"Acta Pathol Jpn"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000183698","article-title":"Glomerulonephritis Associated With Hepatitis B Surface Antigenemia. Report of a Case With Features of Both Membranous and IgA Nephropathy","volume":"42","author":"Magil","year":"1986","journal-title":"Nephron"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/88.1.74","article-title":"Overlapping IgA and Membranous Nephropathy","volume":"88","author":"Jennette","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(98)70031-9","article-title":"Combined Membranous Nephropathy and IgA Nephropathy","volume":"32","author":"Stokes","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13000-016-0538-7","article-title":"Clinicopathological Features of Idiopathic Membranous Nephropathy Combined With IgA Nephropathy: A Retrospective Analysis of 9 Cases","volume":"11","author":"Hu","year":"2016","journal-title":"Diagn Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"11468","DOI":"10.1038\/s41598-017-11838-1","article-title":"Comparison of Prognostic, Clinical, and Renal Histopathological Characteristics of Overlapping Idiopathic Membranous Nephropathy and IgA Nephropathy Versus Idiopathic Membranous Nephropathy","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2018.1455591","article-title":"Characteristics of Patients With Coexisting IgA Nephropathy and Membranous Nephropathy","volume":"40","author":"Chen","year":"2018","journal-title":"Ren Fail"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs491","article-title":"Evaluation of the Chronic Kidney Disease Epidemiology Collaboration Equation for Estimating Glomerular Filtration Rate in the Chinese Population","volume":"28","author":"Kong","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B14","article-title":"Membranous Nephropathy","author":"Churg","year":"1973","journal-title":"Perspect Nephrol Hypertens"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.03.015","article-title":"Development of a Standardized ELISA for the Determination of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy","volume":"421","author":"Dahnrich","year":"2013","journal-title":"Clin Chim Acta"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3118","article-title":"Discovery of New Risk Loci for IgA Nephropathy Implicates Genes Involved in Immunity Against Intestinal Pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.296.5566.261b","article-title":"A Human Genome Diversity Cell Line Panel","volume":"296","author":"Cann","year":"2002","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The Genetic Architecture of Membranous Nephropathy and its Potential to Improve non-Invasive Diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.9362","article-title":"Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial","volume":"318","author":"Lv","year":"2017","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.11.2014","article-title":"Two Different Glomerular Diseases in the Same Patient at an Interval of 7 Years","volume":"17","author":"Frasca","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.1.140","article-title":"Development of IgA Nephropathy 14 Years After Diagnosis of Membranous Nephropathy","volume":"17","author":"Miyazaki","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfm228","article-title":"Barratt J. T-Cell Homing Receptor Expression in IgA Nephropathy","volume":"22","author":"Batra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.029","article-title":"Evaluation of T Helper-1\/-2 Balance on the Basis of IgG Subclasses and Serum Cytokines in Children With Glomerulonephritis","volume":"44","author":"Kawasaki","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.3.513","article-title":"Increased Intestinal Intra-Epithelial T Lymphocytes in Primary Glomerulonephritis: A Role of Oral Tolerance Breakdown in the Pathophysiology of Human Primary Glomerulonephritides","volume":"16","author":"Rostoker","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ng.787","article-title":"Genome-Wide Association Study Identifies Susceptibility Loci for IgA Nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140453","article-title":"Altered Glycosylation of IgG4 Promotes Lectin Complement Pathway Activation in Anti-PLA2R1-Associated Membranous Nephropathy","volume":"131","author":"Haddad","year":"2021","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.7.607","article-title":"Immunoglobulin and Complement Deposition in Glomeruli of 756 Subjects Who had Committed Suicide or Met With a Violent Death","volume":"46","author":"Varis","year":"1993","journal-title":"J Clin Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/4.11.943","article-title":"Frequency of Mesangial IgA Deposits in a Non-Selected Autopsy Series","volume":"4","author":"Waldherr","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"107282","DOI":"10.1016\/j.intimp.2020.107282","article-title":"Immune Characteristics of Renal Allograft Donors With Mesangial IgA Deposition","volume":"91","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.63.6s.2.x","article-title":"Incidence of Latent Mesangial IgA Deposition in Renal Allograft Donors in Japan","volume":"63","author":"Suzuki","year":"2003","journal-title":"Kidney Int"}],"updated-by":[{"DOI":"10.3389\/fimmu.2023.1218427","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.846323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T01:34:26Z","timestamp":1686274466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.846323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2022.846323"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.846323","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"article-number":"846323"}}